Nash Marc 4

What Happened

• Marc Nash, EVP Operations, R&D & Service at Outset Medical, sold 1,817 shares of Outset common stock on February 17, 2026 at $3.35 per share, for proceeds of $6,087. This transaction is reported as a sale (code S) but was a sell-to-cover to satisfy tax withholding related to RSU vesting, not a discretionary cash sale.

Key Details

• Transaction date: 2026-02-17; price: $3.35 per share; total proceeds: $6,087.
• Transaction type: Sale (S); filing includes Footnote F1 indicating the sale was to cover tax withholding on vested RSUs.
• Footnote F1: The sale covered withholding obligations from the vesting of an aggregate 4,384 RSUs granted on 3/15/2021, 7/24/2023, 1/12/2024 and 6/10/2025.
• Shares owned after the transaction: Not specified in the provided filing excerpt.
• Filing date: 2026-02-19 for a 2026-02-17 transaction — appears to be timely (Form 4s are generally due within two business days).

Context

• Sell-to-cover transactions are routine administrative sales to satisfy tax withholding when restricted stock units vest; they do not necessarily indicate the insider is reducing their overall position by choice.
• This was not an options exercise or a discretionary open-market sale for investment purposes; it was executed solely to satisfy tax obligations on vested RSUs.